Eikon Therapeutics: Initiating Coverage With A Cautious Buy Rating
Source: SeekingAlpha
2026-06-12 10:23:13 ET
This is my first time covering Eikon ( EIKN ), a Millbrae, California based biotech that completed its Initial Public Offering [IPO ] in February this year, raising ~$381m at ~$18 per share. The IPO was the largest for a biotech since 2024....
Read the full article on Seeking Alpha
For further details see:
Eikon Therapeutics: Initiating Coverage With A Cautious Buy Rating
Eikon Therapeutics Inc.
NASDAQ: EIKN
EIKN Trading
-2.37% G/L:
$10.30 Last:
103,211 Volume:
$10.50 Open:
EIKN Latest News
$733,647,140
41,190,049
0.21%
N/A
Biotechnology & Life Sciences
Healthcare
US
Millbrae
